Cerity Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.07M | Buy |
38,870
+5,272
| +16% | +$280K | ﹤0.01% | 1202 |
|
|
2025
Q1 | $1.45M | Buy |
33,598
+6,508
| +24% | +$282K | ﹤0.01% | 1257 |
|
|
2024
Q4 | $1.54M | Buy |
27,090
+10,761
| +66% | +$612K | ﹤0.01% | 1220 |
|
|
2024
Q3 | $1.11M | Buy |
16,329
+10,772
| +194% | +$734K | ﹤0.01% | 1349 |
|
|
2024
Q2 | $235K | Sell |
5,557
-2,100
| -27% | -$88.7K | ﹤0.01% | 1946 |
|
|
2024
Q1 | $529K | Buy |
7,657
+2,425
| +46% | +$167K | ﹤0.01% | 1572 |
|
|
2023
Q4 | $387K | Buy |
+5,232
| New | +$387K | ﹤0.01% | 1386 |
|
|
2023
Q3 | – | Sell |
-8,439
| Closed | -$792K | – | 1487 |
|
|
2023
Q2 | $792K | Buy |
8,439
+252
| +3% | +$23.7K | ﹤0.01% | 996 |
|
|
2023
Q1 | $555K | Buy |
8,187
+2,174
| +36% | +$147K | ﹤0.01% | 1246 |
|
|
2022
Q4 | $298K | Buy |
+6,013
| New | +$298K | ﹤0.01% | 1142 |
|
|
2022
Q2 | – | Sell |
-5,189
| Closed | -$362K | – | 1200 |
|
|
2022
Q1 | $362K | Sell |
5,189
-787
| -13% | -$54.9K | 0.01% | 674 |
|
|
2021
Q4 | $463K | Buy |
5,976
+792
| +15% | +$61.4K | 0.01% | 619 |
|
|
2021
Q3 | $495K | Sell |
5,184
-297
| -5% | -$28.4K | 0.01% | 469 |
|
|
2021
Q2 | $681K | Buy |
5,481
+227
| +4% | +$28.2K | 0.01% | 420 |
|
|
2021
Q1 | $692K | Buy |
5,254
+2,265
| +76% | +$298K | 0.02% | 392 |
|
|
2020
Q4 | $396K | Buy |
2,989
+735
| +33% | +$97.4K | 0.01% | 454 |
|
|
2020
Q3 | $230K | Buy |
+2,254
| New | +$230K | 0.01% | 443 |
|
|
2020
Q1 | – | Sell |
-2,163
| Closed | -$200K | – | 467 |
|
|
2019
Q4 | $200K | Sell |
2,163
-252
| -10% | -$23.3K | 0.01% | 507 |
|
|
2019
Q3 | $218K | Sell |
2,415
-77
| -3% | -$6.95K | 0.01% | 442 |
|
|
2019
Q2 | $294K | Sell |
2,492
-1,128
| -31% | -$133K | 0.02% | 403 |
|
|
2019
Q1 | $314K | Sell |
3,620
-503
| -12% | -$43.6K | 0.02% | 410 |
|
|
2018
Q4 | $260K | Buy |
+4,123
| New | +$260K | 0.02% | 430 |
|